LSE - Delayed Quote USD
Moderna, Inc. (0A45.L)
167.05
0.00
(0.00%)
At close: July 21 at 6:35:42 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 13 | 12 | 25 | 24 |
Avg. Estimate | 115.32M | 114.08M | 2.16B | 2.62B |
Low Estimate | 68M | 39M | 1.51B | 1.87B |
High Estimate | 183M | 172M | 2.88B | 5.38B |
Year Ago Sales | 167M | 241M | 3.24B | 2.16B |
Sales Growth (year/est) | -30.95% | -52.66% | -33.21% | 21.41% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0A45.L | -- | -- | -- | -- |
S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/9/2025 |
Maintains | JP Morgan: Underweight to Underweight | 3/21/2025 |
Initiated | Citigroup: Neutral | 3/13/2025 |
Maintains | UBS: Buy to Buy | 2/19/2025 |
Reiterates | RBC Capital: Sector Perform to Sector Perform | 2/18/2025 |
Downgrade | Barclays: Overweight to Equal-Weight | 2/18/2025 |